W-L FreshBurst Listerine Expanded Anticaries Clinical Test Urged By FDA
This article was originally published in The Rose Sheet
Executive Summary
Potential changes to the anticaries and antiplaque/antigingivitis monographs to allow a crossover product must be accompanied by stronger clinical studies than proposed by Warner-Lambert for FreshBurst Listerine with Fluoride, FDA advised the company at a June 6 OTC drug "feedback" meeting in Rockville, Md.